$SLSN|4Feb 26, 9:55 AM ET

NANOPHASE TECHNOLOGIES CORPORATION 4

4 · NANOPHASE TECHNOLOGIES CORPORATION · Filed Feb 26, 2015

Form 4

Period: 2015-02-25

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2015-02-25$0.41/sh+26,000$10,790→ 83,783 total
Exercise/Conversion
Common Stock
2015-02-25$0.30/sh+27,333$8,200→ 57,783 total
Exercise/Conversion
Common Stock (right to buy)
2015-02-25$0.41/sh−26,000$10,790→ 13,000 total
Exercise: $0.41From: 2014-02-14Exp: 2023-02-14→ Common Stock (26,000 underlying)
Exercise/Conversion
Common Stock (right to buy)
2015-02-25$0.30/sh−27,333$8,200→ 13,667 total
Exercise: $0.30From: 2013-08-07Exp: 2022-08-07→ Common Stock (27,333 underlying)

Holdings

Common Stock (right to buy)
Exercise: $1.07From: 2010-06-24Exp: 2019-06-24→ Common Stock (20,000 underlying)
20,000
Common Stock (right to buy)
Exercise: $1.70From: 2011-05-03Exp: 2020-05-03→ Common Stock (20,000 underlying)
20,000
Common Stock (right to buy)
Exercise: $1.26From: 2012-05-02Exp: 2021-05-02→ Common Stock (31,000 underlying)
31,000
Common Stock (right to buy)
Exercise: $0.52From: 2015-02-13Exp: 2024-02-13→ Common Stock (40,000 underlying)
40,000
Common Stock (right to buy)
Exercise: $0.44From: 2016-02-18Exp: 2025-02-18→ Common Stock (36,000 underlying)
36,000

Footnotes (1)

[F1]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Documents

1 file